Company / Operating Cash Flow
ImageneBio, Inc. Operating Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$21.3M
FY2025
5-year range
-$79.7M / -$21.3M
FY2021-FY2025
Trend
+73.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2025 after 3 years of decline, reaching -$21M.
Based on SEC 10-K filings.
-$21M in FY2025.
Improved from -$74M to -$21M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 73.3% year-over-year.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$21.3M | +73.3% |
| FY2024 | -$79.7M | -7.6% |
| FY2023 | -$74.1M | -23.0% |
| FY2022 | -$60.3M | -59.3% |
| FY2021 | -$37.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026